Donor-derived natural killer cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-derived natural killer cell therapy, covering 2025-03-19 to 2025-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors [Phase 2]